New Delhi, Feb. 2 -- The Union Budget 2026-27 focuses on fortifying the Indian economy against global volatility through strategic investments in technology, healthcare, and grassroots entrepreneurship. Industry experts hail the government for their push for strengthening the country's biopharma sector, as well as their focus on women entrepreneurship.
BRICS Chamber of Commerce & Industry Chairman Harvansh Chawla, speaking to ANI, stated that the government directed significant capital toward the biopharma sector to enhance public health infrastructure. "Biopharma is again the need of the hour. India is developing in biopharma, and by investing this Rs 10,000 crore, our Prime Minister and the Modi government have once again proven that t...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.